AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 62 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,625,330 | +82.3% | 1,513,400 | +0.4% | 0.00% | – |
| Q3 2022 | $12,410,000 | +26.0% | 1,507,955 | +0.4% | 0.00% | – |
| Q2 2022 | $9,848,000 | +17.3% | 1,501,317 | 0.0% | 0.00% | – |
| Q1 2022 | $8,392,000 | +22.1% | 1,501,317 | +2.5% | 0.00% | – |
| Q4 2021 | $6,871,000 | -23.7% | 1,465,107 | +0.6% | 0.00% | – |
| Q3 2021 | $9,000,000 | -5.7% | 1,456,230 | +0.6% | 0.00% | – |
| Q2 2021 | $9,541,000 | -5.0% | 1,447,686 | +5.5% | 0.00% | – |
| Q1 2021 | $10,046,000 | +39.0% | 1,372,537 | +9.6% | 0.00% | – |
| Q4 2020 | $7,225,000 | +10.7% | 1,252,147 | +14.0% | 0.00% | – |
| Q3 2020 | $6,524,000 | +16.8% | 1,098,349 | +1.3% | 0.00% | – |
| Q2 2020 | $5,584,000 | +135.8% | 1,084,266 | +65.8% | 0.00% | – |
| Q1 2020 | $2,368,000 | – | 654,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |